Dream Team targets molecular factors common in women's cancers

September 23, 2010
DOI: 10.4016/24154.01
1030 views
URL
Embed
Share

Please describe the reason for abuse:



Description:
First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. MD... » More